Kraig Jacobson is a Rheumatology/Immunology physician affiliated with Allergy Associates Research Center. OpenAlex indexes 34 publications with 1,683 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1488 Oak St
Eugene, OR 974014043
Telephone
541-683-1577Registry record last updated 28 Dec 2010.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Genentech USA, Inc.Program year20242 payments
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
92.3%Leukotriene Receptor Antagonist45.5%Montelukast Sodium100%Part D≥59 patientsCorticosteroid31.4%Trelegy Ellipta33%Fluticasone Propionate28%Arnuity Ellipta26%Fluticasone Propionate Hfa14%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
7.7%Proton pump inhibitor7.7%Pantoprazole Sodium100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
Pediatric Allergy and Immunology
2019 - Safety, efficacy, and pharmacokinetics of intravenous C1 esterase inhibitor (human) prophylaxis in children with hereditary angioedema (HAE)
Journal of Allergy and Clinical Immunology
2019 - Measurement of Functional C1 Inhibitor Levels to Inform Clinical Decision Making in Patients with Hereditary Angioedema: A Case Series
Journal of Allergy and Clinical Immunology
2019 - EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis
International Forum of Allergy & Rhinology
2018 - C1 INHIBITOR ADMINISTRATION IN PEDIATRIC PATIENTS WITH HEREDITARY ANGIOEDEMA: PATIENT COMPLIANCE WITH INTRAVENOUS THERAPY
Annals of Allergy Asthma & Immunology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”